Cromos Pharma, where the patients are

Study Conduct

Sir Stuart Rose to advise on NHS leadership

Friday, February 14, 2014 01:49 PM

Sir Stuart Rose, a highly-regarded business leader in Britain who turned around the fortunes of Marks and Spencer, will advise how the NHS can attract and retain the very best leaders to help transform the culture in under-performing hospitals.

More... »

CRF Health eCOA webinar series

Drugs.com, TrialReach to give patients access to drugs in development

Thursday, February 13, 2014 02:48 PM

Drugs.com, an online clinical drug resource, and TrialReachare partnering to provide patients with information and access to treatments that are still under development. The new partnership will bring TrialReach's patient-centric content and tools directly to the 25 million people who visit Drugs.com every month.

More... »


Parexel rebrands technology subsidiary as Parexel Informatics

Thursday, February 13, 2014 02:06 PM

Global CRO Parexel International has rebranded its Perceptive Informatics subsidiary, which provides the Perceptive MyTrials eClinical platform and other advanced clinical development technology solutions, as Parexel Informatics.

More... »

GSK, Uppsala launch $140.6M European program targeting novel antibiotics

Wednesday, February 12, 2014 01:20 PM

Over 30 European universities, research institutes and companies, led by GlaxoSmithKline and Uppsala University, are joining forces in a six-year program supported by the Innovative Medicines Initiative (IMI) to develop novel antibiotics against Gram-negative pathogens in a project called ENABLE (European Gram-Negative Antibacterial Engine), including open calls for candidates outside the consortium.

More... »

Ulster launches a clinical research network for mental health

Thursday, February 6, 2014 11:47 AM

The University of Ulsterhas launched a dedicated Clinical Research Network for Northern Ireland. The new network means that mental health patients from Northern Ireland can now be involved in major national and international research trials. It also will ensure researchers and health professionals have a better understanding of mental health services.  

More... »

Boston Children's Hospital partners on pharmacogenomics study in pediatric population

Wednesday, February 5, 2014 01:36 PM

Aiming to reduce adverse drug reactions—which affect some 70,000 children annually in the U.S.—a study at Boston Children's Hospital, in partnership with the Medical College of Wisconsin(MCW) and the Children's Hospital of Wisconsin Research Institute, is using genetic information to predict children's reactions to medications, ultimately enabling clinicians to select a more individualized therapy for the patient.

More... »

Local dementia experts visit Russia to share best practices in phase III Alzheimer's study

Wednesday, February 5, 2014 01:29 PM

A doctor-and-nurse team from the Neurological Associates of Albanyclinic will travel to St. Petersburg, Russia, next month to meet with clinical research doctors about TauRx Therapeutics' global phase III clinical trial for mild to moderate Alzheimer's disease. They are invited guests to help share their experience in conducting this study with their Russian counterparts in preparation for the study's launch in Russia.

More... »

NIH grants $1.48M for Massachusetts patient medication adherence study

Wednesday, February 5, 2014 01:21 PM

University of Arizona (UA) associate professor of anthropology Susan J. Shaw and UA assistant professor of pharmacy Jeannie Lee have received $1.48 million from the NIH to study factors that affect medication adherence among residents in Massachusetts, where state law mandates that nearly every resident receive a minimum level of healthcare insurance coverage.

More... »

ACRES, HealthCarePoint strengthen partnership

Wednesday, February 5, 2014 01:18 PM

HealthCarePoint (HCP), a Texas-based healthcare and clinical research networking-technology company, and the Alliance for Clinical Research Excellence and Safety (ACRES), a Cambridge-based nonprofit organization dedicated to enhancing quality, safety, integrity and operational effectiveness in drug development and health research, have announced a second step in their previously announced strategic alliance.

More... »

Janssen R&D launches novel trial data sharing agreement with Yale School of Medicine

Thursday, January 30, 2014 10:49 AM

Johnson & Johnson subsidiary Janssen Research and Development has entered into a novel agreement with Yale School of Medicine's Open Data Access (YODA) Project to extend its commitment to sharing clinical trials data to enhance public health and advance science and medicine. 

More... »

CenterWatch Clinical Trial Survey
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs